These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
352 related articles for article (PubMed ID: 28840619)
1. Adding C-reactive protein and procalcitonin to the model of end-stage liver disease score improves mortality prediction in patients with complications of cirrhosis. Chirapongsathorn S; Bunraksa W; Chaiprasert A; Punpanich D; Supasyndh O; Kamath PS J Gastroenterol Hepatol; 2018 Mar; 33(3):726-732. PubMed ID: 28840619 [TBL] [Abstract][Full Text] [Related]
2. [Prognostic value of procalcitonin, endotoxin and common inflammatory markers combining MELD score in patients with chronic severe hepatitis]. Zhou Q; Tan D; Yi Z; Zheng Y; Lu M Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 38(4):388-94. PubMed ID: 23645239 [TBL] [Abstract][Full Text] [Related]
3. Chronic liver failure-consortium acute-on-chronic liver failure and acute decompensation scores predict mortality in Brazilian cirrhotic patients. Picon RV; Bertol FS; Tovo CV; de Mattos ÂZ World J Gastroenterol; 2017 Jul; 23(28):5237-5245. PubMed ID: 28811718 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of C-reactive protein in cirrhosis: external validation from the CANONIC cohort. Cervoni JP; Amorós À; Bañares R; Luis Montero J; Soriano G; Weil D; Moreau R; Pavesi M; Thévenot T; Di Martino V; Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1028-34. PubMed ID: 27271159 [TBL] [Abstract][Full Text] [Related]
5. Acute phase proteins for the diagnosis of bacterial infection and prediction of mortality in acute complications of cirrhosis. Lazzarotto C; Ronsoni MF; Fayad L; Nogueira CL; Bazzo ML; Narciso-Schiavon JL; de Lucca Schiavon L; Dantas-Corrêa EB Ann Hepatol; 2013; 12(4):599-607. PubMed ID: 23813138 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of C-reactive protein levels in patients with cirrhosis. Di Martino V; Coutris C; Cervoni JP; Dritsas S; Weil D; Richou C; Vanlemmens C; Thevenot T Liver Transpl; 2015 Jun; 21(6):753-60. PubMed ID: 25677965 [TBL] [Abstract][Full Text] [Related]
7. Presepsin teardown - pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis. Papp M; Tornai T; Vitalis Z; Tornai I; Tornai D; Dinya T; Sumegi A; Antal-Szalmas P World J Gastroenterol; 2016 Nov; 22(41):9172-9185. PubMed ID: 27895404 [TBL] [Abstract][Full Text] [Related]
8. Child-Pugh, MELD, and ALBI scores for predicting the in-hospital mortality in cirrhotic patients with acute-on-chronic liver failure. Peng Y; Qi X; Tang S; Deng H; Li J; Ning Z; Dai J; Hou F; Zhao J; Wang R; Guo X Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):971-80. PubMed ID: 27070325 [TBL] [Abstract][Full Text] [Related]
9. Model for End-Stage Liver Disease-Lactate and Prediction of Inpatient Mortality in Patients With Chronic Liver Disease. Sarmast N; Ogola GO; Kouznetsova M; Leise MD; Bahirwani R; Maiwall R; Tapper E; Trotter J; Bajaj JS; Thacker LR; Tandon P; Wong F; Reddy KR; O'Leary JG; Masica A; Modrykamien AM; Kamath PS; Asrani SK Hepatology; 2020 Nov; 72(5):1747-1757. PubMed ID: 32083761 [TBL] [Abstract][Full Text] [Related]
10. Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. Bota DP; Van Nuffelen M; Zakariah AN; Vincent JL J Lab Clin Med; 2005 Dec; 146(6):347-51. PubMed ID: 16310518 [TBL] [Abstract][Full Text] [Related]
12. The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality. Starlinger P; Ahn JC; Mullan A; Gyoeri GP; Pereyra D; Alva-Ruiz R; Hackl H; Reiberger T; Trauner M; Santol J; Simbrunner B; Mandorfer M; Berlakovich G; Kamath PS; Heimbach J Hepatology; 2021 Sep; 74(3):1533-1545. PubMed ID: 33786862 [TBL] [Abstract][Full Text] [Related]
13. Integrated model for end-stage liver disease maybe superior to some other model for end-stage liver disease-based systems in addition to Child-Turcotte-Pugh and albumin-bilirubin scores in patients with hepatitis B virus-related liver cirrhosis and spontaneous bacterial peritonitis. Chen PC; Chen BH; Huang CH; Jeng WJ; Hsieh YC; Teng W; Chen YC; Ho YP; Sheen IS; Lin CY Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1256-1263. PubMed ID: 31498284 [TBL] [Abstract][Full Text] [Related]
14. CLIF-C ACLF score is a better mortality predictor than MELD, MELD-Na and CTP in patients with Acute on chronic liver failure admitted to the ward. Barosa R; Roque Ramos L; Patita M; Nunes G; Fonseca J Rev Esp Enferm Dig; 2017 Jun; 109(6):399-405. PubMed ID: 28467096 [TBL] [Abstract][Full Text] [Related]
15. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil. Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC; Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694 [TBL] [Abstract][Full Text] [Related]
16. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis: a systematic review and meta-analysis. Lin KH; Wang FL; Wu MS; Jiang BY; Kao WL; Chao HY; Wu JY; Lee CC Diagn Microbiol Infect Dis; 2014 Sep; 80(1):72-8. PubMed ID: 24974271 [TBL] [Abstract][Full Text] [Related]
17. C-reactive protein, procalcitonin and the lab-score for detecting serious bacterial infections in febrile children at the emergency department: a prospective observational study. Nijman RG; Moll HA; Smit FJ; Gervaix A; Weerkamp F; Vergouwe Y; de Rijke YB; Oostenbrink R Pediatr Infect Dis J; 2014 Nov; 33(11):e273-9. PubMed ID: 25093971 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of mortality in emergency department sepsis score, procalcitonin, and C-reactive protein in patients with sepsis at the emergency department. Lee CC; Chen SY; Tsai CL; Wu SC; Chiang WC; Wang JL; Sun HY; Chen SC; Chen WJ; Hsueh PR Shock; 2008 Mar; 29(3):322-7. PubMed ID: 17724429 [TBL] [Abstract][Full Text] [Related]
19. Increased Level of Interleukin 6 Associates With Increased 90-Day and 1-Year Mortality in Patients With End-Stage Liver Disease. Remmler J; Schneider C; Treuner-Kaueroff T; Bartels M; Seehofer D; Scholz M; Berg T; Kaiser T Clin Gastroenterol Hepatol; 2018 May; 16(5):730-737. PubMed ID: 28919544 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the prognostic value of Chronic Liver Failure Consortium scores and traditional models for predicting mortality in patients with cirrhosis. Antunes AG; Teixeira C; Vaz AM; Martins C; Queirós P; Alves A; Velasco F; Peixe B; Oliveira AP; Guerreiro H Gastroenterol Hepatol; 2017 Apr; 40(4):276-285. PubMed ID: 28222896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]